Citation Impact
Citing Papers
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
2009 StandoutScience
Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein
2002 StandoutScience
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
Early Autoantibody Responses in Prediabetes Are IgG1 Dominated and Suggest Antigen-Specific Regulation
1999
Heart Failure Outcomes in Clinical Trials of Glucose-Lowering Agents in Patients with Diabetes
2016
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018
Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism
2016
Twelve-week Monotherapy with the DPP-4 Inhibitor Vildagliptin Improves Glycemic Control in Subjects with Type 2 Diabetes
2006
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Inner retinal ischaemia: current understanding and needs for further investigations
2009
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
2000
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study
2001
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
2015
Complementing Insulin Therapy to Achieve Glycemic Control
2013
Nicotinamide inhibits enhanced in vitro production of interleukin-12 and tumour necrosis factor-α in peripheral whole blood of people at high risk of developing Type 1 diabetes and people with newly diagnosed Type 1 diabetes
2000
Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
2014
Liraglutide and Renal Outcomes in Type 2 Diabetes
2017
Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia
2003
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses
2005
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation
2001
Diabetes Mellitus and Heart Failure
2017
Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials
2016
Relationship between blood glucose level and mortality in Type 2 diabetes mellitus: a systematic review
1999
Vitamin D Deficiency
2007 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
The biology of incretin hormones
2006 Standout
Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-ε4 Allele
2003
Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects
1993
The changing landscape of atherosclerosis
2021 StandoutNature
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
2019
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
2000 Standout
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
1998 Standout
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
von Willebrand factor and coronary heart disease. Prospective study and meta-analysis
2002
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1
2005
Type 2 diabetes—Therapy with dipeptidyl peptidase IV inhibitors
2005
Reducing the burden of diabetes: managing cardiovascular disease
1999
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
1994
Diabetes epidemiology as a tool to trigger diabetes research and care
1999
Prediabetes: prediction and prevention trials
2004
Markers of Dysglycaemia and Risk of Coronary Heart Disease in People without Diabetes: Reykjavik Prospective Study and Systematic Review
2010
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Comparison of Treatment and Outcome of Acute Coronary Syndrome in Patients With Versus Patients Without Diabetes Mellitus
2009
β-Cell Autoantibodies, Human Leukocyte Antigen II Alleles, and Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy*
2000
Plasma lipoproteins, apoproteins and cardiovascular disease in Type 2 diabetic patients. A nine-year follow-up study
2003
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Type 2 diabetes
2017 Standout
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Future glucose-lowering drugs for type 2 diabetes
2016
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
2007
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Gut metagenome in European women with normal, impaired and diabetic glucose control
2013 StandoutNature
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Prevalence of Diabetes among Men and Women in China
2010 Standout
Diabetic foot ulcers
2003 Standout
Alzheimer's Disease
2010 Standout
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
2016
The Physiology of Glucagon-like Peptide 1
2007 Standout
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom Prospective Diabetes Study (UKPDS 47)
1999
Triple therapy combinations for the treatment of type 2 diabetes – A network meta-analysis
2016
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies
2017
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
2017
Glycemic control and cardiovascular disease in Type 2 diabetes: a review
1999
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies
2017
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert Forum
2017
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
2016
Mortality and Morbidity in Laboratory-maintained Rhesus Monkeys and Effects of Long-term Dietary Restriction
2003
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
2009
Effects of Icosapent Ethyl on Total Ischemic Events
2019
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial
2018
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type 2 Diabetes
2002
Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?
2016
Adaptive Designs for Clinical Trials
2016
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
2011
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
2017
Intensive Insulin Therapy in the Medical ICU
2006 Standout
Epidemiological Evidence for the Association of Hyperglycaemia and Atherosclerotic Vascular Disease in Non-insulin-dependent Diabetes Mellitus
1996
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
2017
Enzyme activities in quadriceps femoris muscle of obese diabetic male patients
1977
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
2018
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
2013
Risk Factors Predicting Lower Extremity Amputations in Patients With NIDDM
1996
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
2017
Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes
2016
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
2004 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options
2010
von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects
1999
Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes
2016
Diabetes and atherosclerosis: An epidemiologic view
1987
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
2015
Intensive Integrated Therapy of Type 2 Diabetes
2004
Improved Meal-Related β-Cell Function and Insulin Sensitivity by the Dipeptidyl Peptidase-IV Inhibitor Vildagliptin in Metformin-Treated Patients With Type 2 Diabetes Over 1Year
2005
Meglitinide analogues for type 2 diabetes mellitus
2007
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
2015
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence
2015
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
Amelioration of High-Fat Feeding–Induced Insulin Resistance in Skeletal Muscle With the Antiglucocorticoid RU486
1995
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
2019
The safety of dipeptidyl peptidase‐4 (DPP‐4) inhibitors or sodium‐glucose cotransporter 2 (SGLT‐2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta‐analysis
2013
Addition of dipeptidyl peptidase‐4 inhibitors to insulin treatment in type 2 diabetes patients: A meta‐analysis
2017
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
2011
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home
2006
Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.
1997
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Comparison of Vildagliptin and Rosiglitazone Monotherapy in Patients With Type 2 Diabetes
2007
New Drugs for the Treatment of Diabetes
2008
Unchanged Incidence of Lower-Limb Amputations in a German City, 1990–1998
2001
Stimulation of GLP-1 Secretion Downstream of the Ligand-Gated Ion Channel TRPA1
2014
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
Do we know the true mechanism of action of the DPP ‐4 inhibitors?
2017
Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk
2008
A review of dipeptidyl peptidase‐4 inhibitors. Hot topics from randomized controlled trials
2018
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Management of Diabetes Mellitus in Normal Renal Function, Renal Dysfunction and Renal Transplant Recipients, Focusing on Glucagon-Like Peptide-1 Agonist: A Review Based upon Current Evidence
2019
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
2002
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
Incretin therapies: highlighting common features and differences in the modes of action of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors
2015
MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
2019
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
2005
Works of Eberhard Standl being referenced
Muscle metabolism during rest and exercise: influence on the oxygen transport system of blood in normal and diabetic subjects.
1976
A new look at the heart in diabetes mellitus: from ailing to failing
2000
Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics
2001
Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus – a randomized study using positron emission tomography
2004
Current perspectives on cardiovascular outcome trials in diabetes
2016
Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes
2009
Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project
1996
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Guidelines for the treatment and management of new‐onset diabetes after transplantation1
2005
Risk of progression to diabetes of low titer ICA-positive first-degree relatives of type I diabetics in southern Germany
1990
Overview of the management of Type 2 diabetes
1998
Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus
2000
On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth
1993
On the prognosis of IDDM patients with large kidneys
1998
Are there time and cost savings by using telemanagement for patients on intensified insulin therapy?
2002
Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus
2004
Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy
2006
Postprandial Hyperglycemia and Glycemic Variability
2011
Changes of vitamin D3 serum concentrations at the onset of immune-mediated type 1 (insulin-dependent) diabetes mellitus.
1991
Failure of reducing lower extremity amputations in diabetic patients: results of two subsequent population based surveys 1990 and 1995 in Germany.
1998
Muscle triglycerides in diabetic subjects
1980
Prediction of Type 1 Diabetes Postpartum in Patients With Gestational Diabetes Mellitus by Combined Islet Cell Autoantibody Screening: A Prospective Multicenter Study
1997
Insulin degrading enzyme activity and insulin binding of erythrocytes in normal subjects and Type 2 (non-insulin-dependent) diabetic patients
1984
Guidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases: Executive Summary
2007
Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics.
1987
Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
2017
THE PROBLEM OF TISSUE OXYGENATION IN DIABETES MELLITUS
1975
Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease
2007
High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes.
1985
Rimonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes: reply
2007
Twelve- and 52-Week Efficacy of the Dipeptidyl Peptidase IV Inhibitor LAF237 in Metformin-Treated Patients With Type 2 Diabetes
2004
HLA-Associated Insulin Autoantibody Formation in Newly Diagnosed Type I Diabetic Patients
1991
Intensification of Therapeutic Approaches Reduces Mortality in Diabetic Patients With Acute Myocardial Infarction
2004
Delay of Type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial
1998
Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes
1997
Predictors of Incident Heart Failure Hospitalizations Among Patients With Impaired Glucose Tolerance
2013
Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart
2006
Peripheral Vascular Disease in Diabetes Mellitus and Its Relation to Cardiovascular Risk Factors: Screening with the Doppler Ultrasonic Technique
1980
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus
2016